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Abstract
Background: The aim of the study was to test long-term effects of (+)-methamphetamine (MA)
on the dopamine (DA) innervation in limbo-cortical regions of adult gerbils, in order to understand
better the repair and neuroplasticity in disturbed limbic networks.
Methods: Male gerbils received a single high dose of either MA (25 mg/kg i.p.) or saline on
postnatal day 180. On postnatal day 340 the density of immunoreactive DA fibres and calbindin and
parvalbumin cells was quantified in the right hemisphere.
Results: No effects were found in the prefrontal cortex, olfactory tubercle and amygdala, whereas
the pharmacological impact induced a slight but significant DA hyperinnervation in the nucleus
accumbens. The cell densities of calbindin (CB) and parvalbumin (PV) positive neurons were
additionally tested in the nucleus accumbens, but no significant effects were found. The present
results contrast with the previously published long-term effects of early postnatal MA treatment
that lead to a restraint of the maturation of DA fibres in the nucleus accumbens and prefrontal
cortex and a concomitant overshoot innervation in the amygdala.
Conclusion: We conclude that the morphogenetic properties of MA change during maturation
and aging of gerbils, which may be due to physiological alterations of maturing vs. mature DA
neurons innervating subcortical and cortical limbic areas. Our findings, together with results from
other long-term studies, suggest that immature limbic structures are more vulnerable to persistent
effects of a single MA intoxication; this might be relevant for the assessment of drug experience in
adults vs. adolescents, and drug prevention programs.
Background
Methamphetamine (MA) is a common illicit drug, which
abuse is currently reaching epidemic proportions. Accord-
ing to the 2002 SAMHSA National Household Survey on
Drug Abuse, 12.4 million Americans age 12 and older had
tried methamphetamine at least once in their lifetimes
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(5.3 percent of the population). This increasing number is
especially alarming since it has been extensively shown
that MA exerts acute neurotoxic effects on the monoamin-
ergic transmitter systems, and thus leads to characteristic
cognitive impairments like deficits in memory and learn-
ing, psychomotor speed and information processing [1].
It is especially affecting the dopamine (DA) neurons, lead-
ing to dramatic loss of fibres and other DAergic structures
in certain brain areas within a few days [2,3], even after a
single exposure [4].
Some evidence exists that monoaminergic fibres are able
to recover to some extend from this damage during long
time course [5-9]. Moreover, even reactive overshoot was
found for serotonergic fibres in several limbic areas of the
brain, including left entorhinal cortex [10] and the septal
pole of the hippocampal dentate gyrus [11]. For DA fibres,
an early MA treatment produces hyperinnervation in amy-
gdaloid nuclei and ventral entorhinal cortex [12] and a
restraint of the maturation in prefrontal cortex [13,14].
This lab has further shown that the single early MA intox-
ication produces a loss of DA fibres and concomitant
hyperinnervation of serotonin fibres in the nucleus
accumbens (NAC) [15].
Taken together, our recent studies indicate severe changes
in the maturation of the limbo-cortical network following
an early single MA challenge. However, a primary study
has already shown that the neuroplasticity that follows
MA treatment might relate on the age of the animals [4].
Since the functional maturation and aging of the brain is
based on various structural and physiological changes, the
present study was carried out to question whether the
remodelling of neural networks that is induced by the
neurotoxic effects of MA may alter during the lifespan of
gerbils. For that purpose, 6 months old adult gerbils
received a single high dose of MA. At the age of 12 months
the DA innervation was examined in prefrontal cortex,
olfactory tubercle, NAC, and amygdala to check for long-
time effects on the fibre density.
Methods
All experimental procedures were approved by the appro-
priate committee for animal care in accordance with the
guidelines of the European Communities Council Direc-
tive. Breeding gerbils (Meriones unguiculatus) were
obtained from Harlan Winkelmann (Borchen, Germany).
From offspring, a total of 18 males (weight 66–91 g; age
331–348 days) were used in this study. Young animals
were weaned at postnatal day 30 and subsequently sepa-
rated in standard cages (Macrolon® type 4) without any
content except of sawdust. All animals had free access to
food and water and were kept on natural day/night cycles.
On postnatal day 180, a total of 9 gerbils received a single
systemic injection of (+)-methamphetamine hydrochlo-
ride (Sigma, M 8750; 25 mg/kg, i.p.). The other 9 animals
were sham-treated by an i.p. injection of saline. This dose
was chosen due to our former experiences, which have
shown that juvenile gerbils can tolerate higher doses (50
mg/kg) than older ones. Notably, the rate of mortality is
similar at both ages receiving the different doses (unpub-
lished data), indicating physiological changes during the
postnatal maturation of the brain.
The methods used for sectioning and DA immunohisto-
chemistry have been published recently [15]. For the
immunohistochemistry of calbindin and parvalbumin
cells, 50 µm thick vibratome sections were taken from the
same animals (perfused with 100 ml 0.1 M sodium
cacodylate pH 6.2, followed by 750 ml 5% glutaraldehyde
in 0.1 M sodium cacodylate pH 7.6) and treated as fol-
lows: Every third section was collected in 0.05 M Tris-HCL
buffered saline [TBS (pH 7.5)] at 4°C; rinsed 3 × 10 min
in TBS; incubated 10 min with 1% H2O2 in TBS; rinsed
again 3 × 10 min in TBS; blocked in 10% normal goat
serum and 0.4% Triton X-100 (Sigma) for 30 min; incu-
bated with the primary antibody (1:3,000 mouse anti-cal-
bindin, Sigma; 1:2,000 mouse anti-parvalbumin, Sigma)
in 1% normal goat serum and 0.4% Triton X-100 for 18 h;
rinsed 3 × 10 min in TBS; incubated for 30 min in bioti-
nylated goat-anti-mouse antibody (Sigma) diluted 1:20
with 1% normal goat serum; rinsed 3 × 10 min in TBS;
incubated with ExtraAvidin-Peroxidase (Sigma) diluted
1:20 for 30 min; rinsed 3 × 10 min in TBS; stained in
0.05% 3.3-diaminobenzidine (Sigma) with 0.01% H2O2
for 4 min. Finally, the sections were rinsed 5 × 10 min in
TBS, mounted on glass slides, dried overnight, dehydrated
with ethanol, cleared with xylene and cover slipped with
DePeX (Serva, Heidelberg, Germany). To avoid deviations
due to probably lateralised innervation densities of DA or
calcium-binding proteins only right hemispheres were
used for quantification.
For quantification of fibre and cell densities, brain sec-
tions were chosen in areas of interest by means of anatom-
ical characteristics according to brain atlases of the rat [16]
and the mouse [17]. The identification of the brain region
follows the nomenclature of the atlas of the rat. The aver-
age number of analysed sections was 18 per animal for
DA, with a range of 4 up to 6 sections in single regions. In
the defined region of each section (cf. Fig. 1) all detectable
fibre fragments and cells were visualised in standard test
fields (2,080 × 1,544 pixel; 0.22 mm2) using a bright field
microscope (BX61, Olympus, Hamburg, Germany) and a
digital camera for microscopy (ColorView II, SIS, Mün-
ster, Germany) at 200-fold magnification. Cells and fibres
were quantified by software for image analysis (KS300,
Jenoptik, Jena, Germany). Immunoreactive DA fibres of
different diameter were standardised to identical thick-
ness and visualised using a combination of Gauss filterBehavioral and Brain Functions 2006, 2:12 http://www.behavioralandbrainfunctions.com/content/2/1/12
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Dopamine immunoreactive fibres in each of the quantified regions Figure 1
Dopamine immunoreactive fibres in each of the quantified regions. Representative photomicrographs, taken from a 
saline control, of dopamine (DA) immunoreactive fibres of each of the quantified regions. A.1: Prefrontal cortex; A.2: Layer VI 
of the prelimbic area; A.3: Layer IV of the lateral orbital and agranular insular areas. B.1: Nucleus accumbens (NAC); B.2: 
Medial shell of NAC; B.3: Lateral core of NAC; B.4: Olfactory tubercle. C.1: Amygdala (AMY); C.2: Central nucleus of AMY; 
C.3: Basolateral nucleus of AMY. Note the differential innervation pattern and density of DA fibres in the respective regions. 
Scale bars: 1000 µm (A.1, B.1, C.1); 50 µm (A.2-3, B.2-4, C.2-3).Behavioral and Brain Functions 2006, 2:12 http://www.behavioralandbrainfunctions.com/content/2/1/12
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Photomicrographs of Calbindin and Parvalbumin immunoreactive neurons in the nucleus accumbens Figure 2
Photomicrographs of Calbindin and Parvalbumin immunoreactive neurons in the nucleus accumbens. Overview 
(A) and higher magnifications (A1, A2) of the Calbindin innervation of the NAC. The majority of CB+ cells is located in the 
core, which border to the shell is detectable (black arrows). PV+ cells are almost exclusively located in the shell (B1, B2), how-
ever, the overall density is much lower compared to CB+ cells. Scale bars: 2000 µm (A, B); 200 µm (A1, B1); 100 µm (A2, B2).Behavioral and Brain Functions 2006, 2:12 http://www.behavioralandbrainfunctions.com/content/2/1/12
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and Gerig operator that depicts differences of grey values
of adjacent pixels and transforms the result into binary
images. The DA fibre density was computed as a percent-
age of the evaluated test area. Calbindin and parvalbumin
positive cells were detected by use of a threshold to the
grey value, followed by automatic sorting of adequate
shape and minimal size (250 pixels) of the structures.
Remaining structures were classified as cells, the size of
the structures (cell area) being measured cumulatively
and the according cell density calculated by proportion of
cell number per test field area. Calbindin-positive cells are
located almost exclusively in the core region of the NAC
and were measured only in this part of the NAC, whereas
medium-sized PV-positive cells are specific to the shell
and were counted only in this area. All analyses were done
by a person blind to the pharmacological treatment of
individual animals.
Dopamine innervation density in four regions of the gerbil brain Figure 3
Dopamine innervation density in four regions of the gerbil brain. Dopamine (DA) innervation density ± S.E.M. is pre-
sented in four regions of the gerbil brain, namely agranular insular and lateral orbital as well as prelimbic areas of the prefrontal 
cortex, the olfactory tubercle, core and shell areas of the nucleus accumbens (NAC), and the central and basolateral nuclei of 
the amygdala complex. Methamphetamine treatment generally tends to increase the DA innervation. However, a significant 
region-specific change in response to a single adult methamphetamine treatment exclusively occurs in the shell of the NAC 
(+11%; p = 0.0332). The difference in the core appears somewhat more pronounced but is not significant due to higher vari-
ance (+21%; p = 0.1011). Student's t-Test, significance value: * p < 0.05. Following methamphetamine treatment, ANOVA 
detected a significant overall increase of DA innervation in core and shell of the NAC (F(1,16) = 4.7316; p = 0.0472).Behavioral and Brain Functions 2006, 2:12 http://www.behavioralandbrainfunctions.com/content/2/1/12
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The measurements were computed as arithmetic means
by-case and by-group ± S.E.M. of the respective regions
(Fig. 3). Statistical analysis revealed regional effects of MA
treatment by the use of Student's t-test. General alterations
in the NAC were additionally investigated by use of 2-way
analysis of variance (ANOVA), which checked for area-
specific and group-specific effects [18]. Data analysis was
computed with Statistica 6 (StatSoft, Tulsa, USA). The lev-
els of significance were set at * p < 0.05, ** p < 0.01, and
*** p < 0.001.
Results
The innervation pattern of DA immunoreactive fibres in
gerbils is generally in line with the results of rats. The
innervation pattern and density of DA immunoreactive
fibres in the gerbil forebrain are region-specific (Figs. 1
and 3). Representative photographs of the differential DA
innervation densities and patterns of the four regions that
were subsequently studied in more detail are provided in
Fig. 1, taken from a male gerbil of the saline group.
Quantitative DA data were obtained from a total of 327
sections that derived from 18 gerbils of two experimental
groups (Saline n = 9, MA n = 9). The adult single systemic
MA challenge induces no general alteration of DA inner-
vation pattern in the investigated regions of the gerbil
brain (Fig. 3). The overall DA fibre density in the NAC is
selectively increased by MA [(ANOVA, F(1,16) = 4.7316,
p = 0.0472) please note that ANOVA included compari-
son of 8 vs. 8 animals only, because some NAC sections
were damaged in one animal of each experimental group].
However, the significant increase (+11%) is limited to the
shell (Student's t-test, p = 0.0332), whereas alteration in
the core misses statistical significance (Student's t-test, p =
0.1011). No change in DA fibre density was found in the
prefrontal cortex, olfactory tubercle and amygdala.
To determine other potential alterations within the NAC,
CB- and PV- positive structures were additionally investi-
gated in this area. The distribution of CB- and PV-positive
subpopulations in the gerbil generally resembles the dis-
tribution in the NAC of rats and primates (Fig. 2) [19-21].
A single adult MA intoxication caused no significant alter-
ation in the cell density of either CB- positive neurons or
PV-positive neurons in the NAC. Neither was there a dif-
ference in the cell areas (Fig. 4).
Discussion
According to our results, a single adult MA challenge
induces minor long-term changes of the DA innervation
Calbindin and parvalbumin cell densities and cell areas in the nucleus accumbens Figure 4
Calbindin and parvalbumin cell densities and cell areas in the nucleus accumbens. Calbindin (CB) and parvalbumin 
(PV) cell densities and cell areas ± S.E.M. are presented for the nucleus accumbens (NAC). PV-positive cells and CB-positive 
cells are predominantly located in the shell and in the core of the NAC, respectively, where they were quantified. No statisti-
cally significant effect of a single adult methamphetamine challenge could be detected for either number (cell density) or cumu-
lative size (cell area) of both PV and CB cells. Generally, the number of CB cells is considerably higher and their average size is 
doubled compared to PV cells.Behavioral and Brain Functions 2006, 2:12 http://www.behavioralandbrainfunctions.com/content/2/1/12
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in the NAC, whereas other regions of the limbocortical cir-
cuitry are apparently unaffected. These results contrast
with previously published data on the long-term effects of
early postnatal MA treatment that demonstrated a
restraint maturation of DAergic fibres in the NAC and the
prefrontal cortex [14,22] and a concomitant overshoot
innervation in the amygdala [12]. Table 1 provides a com-
parison between MA effects on DA innervation in juvenile
and adult gerbils.
Postnatal development and vulnerability to 
methamphetamine
The age-related and region-specific alterations that are
triggered by a single MA-treatment of gerbils might reveal
the complexity of MA neurotoxicity. It has to be pointed
out that the different doses that were administered to
juvenile (50 mg/kg) [10-15,22] vs. adult (25 mg/kg, cur-
rent study) animals may be even more adequate for com-
paring age-related effects than using the same dose in both
ages, because a lethal dose of MA is approximately also
twice as high in juvenile gerbils compared to adults
(unpublished data), indicating physiological changes dur-
ing postnatal maturation of the brain. The reasons for the
age-dependent differences in vulnerability to MA in ger-
bils are currently not clear. However, it appears reasonable
to assume that this is related to physiological alterations
in maturing vs. mature monoaminergic neurons. Gener-
ally, the high amount of MA that is required to induce
such effects might be specific to gerbils, probably due to
species-specific metabolic enzymes.
Although the exact molecular mechanism of MA neuro-
toxicity is still not completely understood, it is clear that
developmental alteration must play an important role in
mediating the MA-induced effects [23]. This is demon-
strated by the finding that the application of MA results in
higher mortality and stronger reactions of adult gerbils
compared to juveniles or adolescents [4,24-29], which
may be understandable by reports that, in rats, higher MA
concentrations occur in the brains of 90 days old versus
40 days old animals after receiving the same dose [25,29].
However, Kokoshka and colleagues published some
intriguing results which on the one hand confirmed pre-
vious studies concerning the lack of medium-term (7
days) deficits in the DA systems after MA treatment in
adolescent rats, but on the other hand showed that there
were acute short-term (1 hour) consequences in adoles-
cent (40 days) and adult (90 days) rats [25]. Further, MA-
induced behavioural sensitization, which is a prominent
feature of MA administration [30,31], seems to be age-
dependent [32]. It does not occur within a crucial postna-
tal period, which in turn seems to correspond to the time
of presynaptic DA autoreceptor formation in the brain
[33].
Several parameters of the DA system underlie develop-
mental changes, e.g. DAT expression [34,35], expression
of DA receptors and DA concentration [36], and activity of
the vesicular monoamine transporter-2 (VMAT-2) [29].
The mechanism underlying the modifications seen in
adult animals after MA challenge is therefore thought to
vary from the one mediating the neurotoxic effect in juve-
nile animals. The ability of a single early MA challenge to
selectively induce a restraint of the maturation of DA
fibres in the prefrontal cortex and the NAC [14,22,37] as
well as a concomitant excessive maturation in several
amygdaloid nuclei and the entorhinal cortex [12] might
be due to a special vulnerability of immature fibre systems
[38]. As DA transmission in the NAC seems to play a crit-
ical role in an input selection mechanism that regulates
the influence of certain inputs over neural activity [39],
the reactive changes that occur within local circuits fol-
lowing the MA challenge might cause a new and different
innervation pattern of these fibres and thus a neuroana-
tomical restructuring [40,41]. The severe impairment of
the brain architecture induced by a single early MA treat-
ment clearly demonstrates that despite the apparent
higher resistance of younger animals, MA is indeed a
potent drug capable of inducing extensive structural alter-
ations in the juvenile brain that persist into adulthood.
Table 1: Comparison of age-related long-term effects of a single methamphetamine intoxication on the dopamine innervation in 
limbocortical areas of the gerbil brain.
Adult (current study) MA 1 × 25 
mg/kg i.p., p180
Juvenile [Reference] MA 1 × 50 
mg/kg i.p., p14
Prefrontal cortex Medial ↔ n.s. ↓ – 38% ** [14]
Orbital ↔ n.s. ↓ – 50% ** [14]
Nucleus accumbens Core ↔ n.s. ↓ – 28% * [15]
Shell ↑ +11% * ↔ n.s. [15]
Amygdala Basolateral ↔ n.s. ↑ +18% ** [12]
Central ↔ n.s. ↔ n.s. [12]
Olfactory Tubercle ↔ n.s No data
Significance values: * p < 0.05, ** p < 0.01.Behavioral and Brain Functions 2006, 2:12 http://www.behavioralandbrainfunctions.com/content/2/1/12
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Effects of methamphetamine on different 
neurotransmitters and brain regions
It was reported that the mechanism of MA neurotoxicity
includes the formation of reactive oxygen [42-44] and
nitrogen [42,45,46] species, which damage monoaminer-
gic neurons. However, several other factors may also con-
tribute in mediating the neurotoxic effect of MA, leading
to region-specific and neuron-specific differences in vul-
nerability. Fumagalli and colleagues have shown that rats
lacking the dopamine transporter (DAT) are protected
against the MA-related neurotoxicity in the striatum [47].
Interestingly, impairment in the function of VMAT-2,
which accumulates cytoplasmic DA into synaptic vesicles
as seen in mice heterozygous for this transporter, increases
the MA neurotoxicity [48]. It has also been demonstrated
that the blockage of either DA D1 or D2 receptors prevents
the damage of repeated doses of MA to striate DA termi-
nals [49] and that there are regional differences in sensi-
tivity of these terminals to the MA [4,50]. It seems likely
that DAT and DA receptors may be factors limiting the
severity of neurotoxic effects of MA, presumably by influ-
encing the concentration and distribution of DA.
MA-induced alterations have also been found in other
neuronal elements like 5-HT fibres [10,15,51,52],
GABAergic neurons [53], and the morphology of cortical
pyramidal cells [54]. Our animal model has also revealed
that glutamatergic projection fibres from the mediodorsal
prefrontal cortex to several other cortical areas are signifi-
cantly reduced after an early single MA intoxication [55].
Interestingly, in the present study the shell of the NAC is
the only area that reacts to a single adult MA challenge,
and it is also almost the only area we have studied lacking
any effect of the DA fibre density in response to a single
postnatal drug treatment [12,14,15] (cf. Table 1). In con-
trast, the core region of the NAC exhibits a strong decline
in DA fibre density after an early single MA administration
[15]. This is in line with results from Broening and col-
leagues, who, after repeated MA treatment of rats, found
an almost completely loss of tyrosine hydroxylase immu-
noreactivity in the core while the shell was almost spared
[56]. In addition, most drugs increase extracellular DA lev-
els preferentially in the shell region of the NAC [57],
which coincides with differences in DA baseline levels
[57,58], and different time-course of the maturation of
the DA innervation in the core and shell areas [59]. We
may conclude that the DA fibre systems of the brain are far
from being homogeneous; thus, statements on the general
effects of MA intoxication on DA fibres are misleading.
Regeneration and reorganisation of neural networks: 
implications for psychiatric diseases
It has been shown before that DA fibres can be rebuilt
within 24 weeks after a lesion of the NAC with 6-OHDA
[60]. Furthermore, Finkelstein and colleagues could show
that a lesion to the substantia nigra causes sprouting of
DA fibres in the striatum of rats [61]. Thus, the increased
fibre density we have found in the NAC might probably
be caused by a specific regeneration rather than a reorgan-
isation of fibres.
Several studies in humans and rodents have shown that
the effects of MA are to a large extend reversible, although
this process might last many years and may strongly
depend on the severity and duration of the drug abuse [1].
We have shown that a single administration of MA on
postnatal day 90 leads to a transient increase of the den-
dritic spine density of prefrontal pyramidal neurons,
which regain an almost normal level within 30 days post-
treatment [62]. In the present study, we apparently pro-
vided sufficient time for the impaired system to recover
from MA intoxication and to eventually regain normal DA
fibre densities. Our model using only a single administra-
tion of MA may therefore be more useful to mimic the
effects on first time users rather than on chronically abus-
ers of the drug. In addition, it has been shown that inter-
mittent treatment with MA can lead to the development of
tolerance to its neurotoxic effects [63-65]. Thus the para-
digm of repeated administration of MA as used in the
majority of studies might either conceal or modify the del-
eterious effects of the psychostimulant. In fact, some stud-
ies have shown opposed or stronger effects of single versus
chronic administration of MA [66,67].
Chronic MA use is known to cause psychotic symptoms
that mimic that of schizophrenia [68-70]. Further, we
could recently show that an early single intoxication leads
to a 'dysconnection' of prefrontal efferents [55], thus pro-
viding an anatomical correlate of schizophrenia [71,72].
This is consistent with results from Chen and colleagues
who revealed an association between earlier and larger use
of MA with higher risk of psychosis in humans [68].
Conclusion
The results of this study show that even a single applica-
tion of MA to adult gerbils may induce long-term physical
alterations in limbic brain areas, although the effects are
not as severe as seen after an early drug challenge. The
increased DAergic fibre density in the NAC indicates reac-
tive over-sprouting, which possibly is a response to altered
network requirements after MA treatment. It remains to
be investigated whether other brain areas would reveal
short-term modifications, which might be concealed by
recovery in this approach. While it cannot be excluded
that the different effects in adult vs. juvenile gerbils are, at
least in part, due to the different doses of MA, several
other studies also indicate changes in MA effects that
depend on the age of rats and mice. We thus may con-
clude that, in rodents, MA not only acts age-dependent,
but also highly region-specific. We have sufficient evi-Behavioral and Brain Functions 2006, 2:12 http://www.behavioralandbrainfunctions.com/content/2/1/12
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dence to suggest that early contact with this psychotropic
substance during childhood might increase the risk of per-
sistent severe structural changes of the brain architecture
and may result in long-term cognitive and psychiatric dis-
turbances.
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